Yuyu Pharma Pref Shs (000227) Stock Price & News

000227:KRX

Yuyu Pharma Pref Shs

₩ 7,730.00

-0.13%

(-10.00) 1D

10-р сарын 19, 12:30:30 (GMT+9) · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 000227...

Open

₩ 8,000

High

₩ 8,000

Low

₩ 7,730

Mkt. cap

70.71 тэрбум

Avg. vol.

1.25 мян

Volume

98.00

Dividend

1.49%

Quarterly dividend

₩ 29

Ex-dividend date

2024 оны 12-р сарын 27

P/E ratio

11.55

52-wk high

₩ 12,400

52-wk low

₩ 5,810

EPS

₩ 669

Shares outstanding

322.96 мян

No. of employees

243

Open

₩ 8,000

High

₩ 8,000

Low

₩ 7,730

Mkt. cap

70.71 тэрбум

Avg. vol.

1.25 мян

Volume

98.00

Dividend

1.49%

Quarterly dividend

₩ 29

Ex-dividend date

2024 оны 12-р сарын 27

P/E ratio

11.55

52-wk high

₩ 12,400

52-wk low

₩ 5,810

EPS

₩ 669

Shares outstanding

322.96 мян

No. of employees

243

Related stocks

Yuhan Corp Preference Shares

₩ 71,200.00

+6.59%

000240

Hankook & Company Co Ltd

₩ 26,300.00

0.00%

News stories

From web sources and news partners

01net

1 цагийн өмнө

OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight as the Agentic Foundation for Its Up to $1 Billion Tokenized Solar and AI Computing Program with Meridian and Up to $130 Million IP-Backed Transaction with BeyondAI

TradingView

22 минутын өмнө

No ‘Black Monday’? Nasdaq, S&P 500, Dow Futures Spike As Big Tech Earnings Loom This Week — Retail Stays Cautious

BigGo Finance

24 минутын өмнө

South Korea's FSS Chief Says Solidigm's Nasdaq Listing Would Constitute Duplicate Listing, Hints at Conveying Concerns to SK Hynix

Bloomberg.com

6 цагийн өмнө

US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap

About Yuyu Pharma Pref Shs

CEO-

Employees243

Founded1941

Headquarters-

SectorPharmaceutical industry

Websiteyuyu.co.kr

Revenue

Net income

All values in KRW	2025 оны 9-р сар	2025 оны 12-р сар	2026 оны 3-р сар	2026 оны 6-р сар
Revenue	37.79 тэрбум	34.34 тэрбум	35.54 тэрбум	36.70 тэрбум
Cost of goods sold	23.00 тэрбум	22.54 тэрбум	21.04 тэрбум	22.11 тэрбум
Cost of revenue	23.00 тэрбум	22.54 тэрбум	21.04 тэрбум	22.11 тэрбум
Research and development expenses	914.90 сая	1.15 тэрбум	703.42 сая	781.89 сая
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	8.71 тэрбум	10.17 тэрбум	8.95 тэрбум	9.33 тэрбум
Operating expense	9.81 тэрбум	11.93 тэрбум	10.19 тэрбум	10.59 тэрбум
Total operating expenses	32.81 тэрбум	34.47 тэрбум	31.24 тэрбум	32.69 тэрбум
Operating income	4.99 тэрбум	-129.07 сая	4.30 тэрбум	4.00 тэрбум
Other non operating income	56.65 сая	-1.13 тэрбум	863.61 сая	-184.40 сая
EBT including unusual items	4.82 тэрбум	202.03 сая	3.97 тэрбум	4.13 тэрбум
EBT excluding unusual items	4.77 тэрбум	-1.11 тэрбум	4.99 тэрбум	3.68 тэрбум
Income tax expense	504.29 сая	-1.00 тэрбум	620.45 сая	574.52 сая
Effective tax rate	10.46%	-496.97%	15.62%	13.91%
Other operating expenses	18.27 сая	76.24 сая	40.94 сая	36.86 сая
Net income	3.98 тэрбум	1.39 тэрбум	3.49 тэрбум	3.65 тэрбум
Net profit margin	10.52%	4.03%	9.82%	9.95%
Earnings per share	-	-	-	-
Interest and investment income	136.07 сая	529.96 сая	286.44 сая	226.76 сая
Interest expense	-540.35 сая	-547.07 сая	-474.32 сая	-436.45 сая
Net interest expenses	-404.28 сая	-17.11 сая	-187.88 сая	-209.69 сая
Depreciation and amortization charges	320.96 сая	403.34 сая	334.87 сая	409.27 сая
EBITDA	6.34 тэрбум	1.33 тэрбум	5.68 тэрбум	5.46 тэрбум
Gain or loss from assets sale	-13.34 сая	-	-499.00 мян	-3.19 сая

Ask anything